Pluri Inc.
PLUR | TA
Overview
Corporate Details
- ISIN(s):
- US72942G2030
- LEI:
- Country:
- Israel
- Address:
- Park Building No. 5, 3508409 Haifa
- Website:
- https://pluri-biotech.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Pluri develops cell-based therapeutic solutions, focusing on regenerative medicine and tissue repair, headquartered in Israel.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-03 22:43 |
Post-Annual General Meeting Information
Immediate Report
|
Hebrew (modern) | 224.6 KB | |
| 2025-07-03 22:43 |
Foreign Filer Report
Immediate Report
|
English | 36.5 KB | |
| 2025-07-02 01:15 |
Director's Dealing
Other Report or Announcement
|
English | 267.8 KB | |
| 2025-07-02 01:15 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB | |
| 2025-05-28 21:57 |
Proxy Solicitation & Information Statement
mediate Report of Meeting to be held on June 30, 2025
|
English | 1.4 MB | |
| 2025-05-28 21:57 |
Pre-Annual General Meeting Information
mediate Report of Meeting to be held on June 30, 2025
|
English | 184.6 KB | |
| 2025-05-28 01:52 |
Annual Report
Materials for Annual Meeting - Annual Report for 30.06.2024
|
English | 346.4 KB | |
| 2025-05-28 01:52 |
Foreign Filer Report
Materials for Annual Meeting - Annual Report for 30.06.2024
|
English | 36.3 KB | |
| 2025-05-28 01:36 |
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on June 30, 2025, proxy
|
English | 1.4 MB | |
| 2025-05-28 01:36 |
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on June 30, 2025, proxy
|
English | 161.1 KB | |
| 2025-05-27 17:56 |
Pre-Annual General Meeting Information
FORM 8K – Updated Regurding Annual Meeting Date
|
English | 112.3 KB | |
| 2025-05-27 17:56 |
Foreign Filer Report
FORM 8K – Updated Regurding Annual Meeting Date
|
English | 36.3 KB | |
| 2025-05-20 17:26 |
Major Shareholding Notification
Form 13D/A-Yaky Yanay
|
English | 168.9 KB | |
| 2025-05-20 17:26 |
Foreign Filer Report
Form 13D/A-Yaky Yanay
|
English | 36.2 KB | |
| 2025-05-15 16:02 |
Management Discussion and Analysis
Pluri CEO Issues Shareholder Letter
|
English | 110.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Ascelia Pharma | Sweden | ACE | |
|
Atrys Health S.A. | Spain | ATRY | |
|
AUKETT SWANKE GROUP PLC | United Kingdom | AUK | |
|
Azorean - Aquatic Technologies S.A. | Portugal | MLAAT | |
|
Bachem Holding AG | Switzerland | BANB | |
|
Bavarian Nordic | Denmark | BAVA | |
|
BB Biotech AG | Switzerland | BION | |
|
BEEKS FINANCIAL CLOUD GROUP PLC | United Kingdom | BKS | |
|
BenevolentAI | United Kingdom | BAI | |
|
BerGenBio | Norway | BGBIO |